Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling

Sep 6, 2019Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Astragaloside IV may reduce lung scarring caused by silica by blocking a key cell signaling pathway

AI simplified

Abstract

20 μg/mL astragaloside ASV effectively reduces the expression of collagen in silicosis fibroblasts.

  • ASV inhibits the transformation of fibroblasts into myofibroblasts.
  • TGF-β1 stimulates fibroblast proliferation and promotes the phosphorylation of Smad2 and Smad3 while down-regulating Smad7 expression.
  • Continuous phosphorylation of Smad3 is a key factor associated with fibrosis.
  • ASV may inhibit silica-induced lung fibrosis through the TGF-β1/Smad3 signaling pathway.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free